BIOMERICA INC

Biomerica Inc. (CIK 73290) is a developer of niche life science diagnostics tools rooted in the reagents and instrumentation that support gastroenterology, diabetes, and toxicology testing—products spanning immunoassay kits, rapid tests, and clinical lab instrumentation that serve healthcare systems, clinical laboratories, and point-of-care settings alike. Operating in the broader small-cap SIC 2833/8731 segment where emerging diagnostics firms orbit the overlapping worlds of medical device regulation and laboratory services, the company must navigate Federal Food, Drug, and Cosmetic Act scrutiny along with CLIA requirements and reimbursement pressures that heighten the sensitivity of its growth trajectory. With retail and clinical customers increasingly demanding ISO-compliant quality and digital reporting compatibility, Biomerica emphasizes lean manufacturing and cross-border distribution resilience to offset supply-chain volatility and currency risk. The latest SEC filing remains unavailable, but market watchers can stay current by viewing live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025